MetaCap

Eton Pharmaceuticals (ETON) vs Maravai LifeSciences (MRVI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Eton Pharmaceuticals (ETON) has outperformed Maravai LifeSciences (MRVI) over the past year, gaining 269.7% versus a gain of 86.1%. Over five years, ETON leads with a +1341.9% price change compared with -83.2% for MRVI. Maravai LifeSciences is the larger company by market cap ($1.81 billion vs $1.76 billion), about 1.0 times the size, while Eton Pharmaceuticals is growing revenue faster (+104.9% vs -28.3%).

Eton Pharmaceuticals converts more of its revenue into profit, with a net margin of -5.8% versus -70.4%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ETON+269.68%MRVI+86.13%
+333%+146%-42%
Nov 21, 20251 yearNov 20, 2026
ETON+1234.43%MRVI-81.37%
+1372%+603%-165%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ETON versus MRVI key metrics
MetricETONMRVI
Share price$60.85$6.98
Market cap$1.76B$1.81B
1-day change-0.83%-2.92%
YTD return+259.85%+114.77%
1-year return+269.68%+86.13%
5-year return+1341.94%-83.18%
P/E ratio (TTM)39.51—
Forward P/E18.41—
EPS (TTM)$1.54$-0.44
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$79.95M$185.74M
Revenue growth (YoY)+104.94%-28.34%
Net income (latest FY)$-4.60M$-130.77M
Gross margin53.46%18.30%
Operating margin-1.06%-115.89%
Net margin-5.75%-70.41%
52-week high$70.64$9.42
52-week low$14.27$2.80
Distance from 52-week high-13.86%-25.90%
Analyst consensusstrong_buybuy
Avg. price target upside+32.70%+38.11%
Average volume570.79K2.72M
Shares outstanding28.84M149.25M
Employees44410
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ETON has outperformed MRVI by 183.6 percentage points over the past year.
  • Eton Pharmaceuticals is more profitable, keeping -5.8 cents of every revenue dollar as net income versus -70.4 cents for Maravai LifeSciences.
  • Eton Pharmaceuticals grew revenue faster in its latest fiscal year (+104.94% vs -28.34%).

About Eton Pharmaceuticals

ETON stock →

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1.

Health Care · Biotechnology: Pharmaceutical Preparations · 44 employees

About Maravai LifeSciences

MRVI stock →

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS.

Health Care · Biotechnology: Pharmaceutical Preparations · 410 employees

ETON vs MRVI FAQ

Which is bigger, Eton Pharmaceuticals or Maravai LifeSciences?

Maravai LifeSciences (MRVI) is larger, with a market capitalization of $1.81B compared with $1.76B for Eton Pharmaceuticals (ETON).

Which stock has performed better over the past year, ETON or MRVI?

ETON returned +269.68% over the past 12 months, compared with +86.13% for MRVI (price return, excluding dividends). Past performance does not predict future results.

Are Eton Pharmaceuticals and Maravai LifeSciences in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons